LCM
MEDP icon

Legato Capital Management’s Medpace MEDP Stock Holding History

Legato Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$350K Sell
661
-639
-49% -$295K 0.03% 558
2026
Q1 		$624K Buy
1,300
+543
+72% +$278K 0.06% 477
2025
Q4 		$425K Sell
757
-327
-30% -$186K 0.04% 613
2025
Q3 		$557K Sell
1,084
-26
-2% -$11.4K 0.06% 431
2025
Q2 		$348K Hold
1,110
– – 0.04% 484
2025
Q1 		$338K Sell
1,110
-115
-9% -$38.7K 0.05% 473
2024
Q4 		$407K Hold
1,225
– – 0.05% 469
2024
Q3 		$409K Sell
1,225
-3,463
-74% -$1.32M 0.05% 469
2024
Q2 		$1.93M Sell
4,688
-1,922
-29% -$761K 0.26% 123
2024
Q1 		$2.67M Sell
6,610
-1,299
-16% -$457K 0.32% 85
2023
Q4 		$2.42M Sell
7,909
-474
-6% -$128K 0.32% 77
2023
Q3 		$2.03M Buy
8,383
+969
+13% +$248K 0.29% 92
2023
Q2 		$1.78M Hold
7,414
– – 0.24% 132
2023
Q1 		$1.39M Hold
7,414
– – 0.25% 125
2022
Q4 		$1.57M Buy
+7,414
New +$1.48M 0.3% 99

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Legato Capital Management's MEDP Position: Q2 2026 in Review

Legato Capital Management reduced its Medpace (MEDP) stake by 49% in Q2 2026, selling an estimated $295K and leaving 661 shares worth $350K. The position accounts for 0.03% of the portfolio, ranked #558.

Legato Capital Management first reported a position in MEDP in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.67M in Q1 2024. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Legato Capital Management held 661 shares of Medpace worth $350K as of Q2 2026.
  • Legato Capital Management sold 639 Medpace shares in Q2 2026, an estimated $295K.
  • Medpace made up 0.03% of Legato Capital Management's portfolio in Q2 2026, its #558 holding.
  • Legato Capital Management first reported a position in Medpace in Q4 2022 and has held it in 15 quarters since.
  • Legato Capital Management's Medpace position peaked at $2.67M in Q1 2024.
  • 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.